Showing results (181-190 of 208) with videos related to
Sort By:
Pageof 21
Thrombosis Research|March 27, 2017
Impact of rivaroxaban on point-of-care assaysPierre Fontana, Lorenzo Alberio, Anne Angelillo-Scherrer, et al.Hepatology Communications|July 22, 2024
High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorderAlexander Coukos, Chiara Saglietti, Christine Sempoux, et al.Journal of Thrombosis and Haemostasis : JTH|February 26, 2021
Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolismDaniel Röshammar, Fenglei Huang, Manuela Albisetti, et al.Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolismManuela Albisetti, Branislav Biss, Lisa Bomgaars, et al.Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and designMatteo Luciani, Manuela Albisetti, Branislav Biss, et al.Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.Frontiers in Cardiovascular Medicine|September 27, 2021
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban MeasurementsTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisC Heleen van Ommen, Manuela Albisetti, Mohir Bhatt, et al.Frontiers in Cardiovascular Medicine|April 4, 2022
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional StudyTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.Journal of Clinical Medicine|April 13, 2023
Long-Term Consequences of COVID-19: A 1-Year AnalysisLaurence Bamps, Jean-Philippe Armenti, Mirela Bojan, et al.Pageof 21